Full Press Release Details
| AGILENT TECHNOLOGIES, INC. | ||||||||||||||||
| LIFE SCIENCES AND DIAGNOSTICS MARKETS SEGMENT | ||||||||||||||||
| (Unaudited) | ||||||||||||||||
| (In millions, except margins data) | FY24 | |||||||||||||||
| Q1 | Q2 | Q3 | Q4 | Total | ||||||||||||
| Revenue | $ | 620 | $ | 604 | $ | 585 | $ | 657 | $ | 2,466 | ||||||
| Gross margin % | 54.9 | % | 55.1 | % | 54.4 | % | 53.8 | % | 54.5 | % | ||||||
| Research and development expenses | $ | 66 | $ | 64 | $ | 59 | $ | 61 | $ | 250 | ||||||
| Selling, general and administrative expenses | $ | 160 | $ | 154 | $ | 145 | $ | 152 | $ | 611 | ||||||
| Income from operations | $ | 114 | $ | 115 | $ | 114 | $ | 141 | $ | 484 | ||||||
| Operating margin % | 18.4 | % | 19.0 | % | 19.6 | % | 21.5 | % | 19.6 | % | ||||||
| FY23 | ||||||||||||||||
| Q1 | Q2 | Q3 | Q4 | Total | ||||||||||||
| Revenue | $ | 719 | $ | 726 | $ | 661 | $ | 674 | $ | 2,780 | ||||||
| Gross margin % | 57.2 | % | 57.0 | % | 56.5 | % | 55.8 | % | 56.7 | % | ||||||
| Research and development expenses | $ | 71 | $ | 72 | $ | 61 | $ | 65 | $ | 269 | ||||||
| Selling, general and administrative expenses | $ | 169 | $ | 166 | $ | 147 | $ | 151 | $ | 633 | ||||||
| Income from operations | $ | 171 | $ | 176 | $ | 166 | $ | 160 | $ | 673 | ||||||
| Operating margin % | 23.8 | % | 24.2 | % | 25.1 | % | 23.7 | % | 24.2 | % | ||||||
| FY22 | ||||||||||||||||
| Q1 | Q2 | Q3 | Q4 | Total | ||||||||||||
| Revenue | $ | 670 | $ | 690 | $ | 718 | $ | 766 | $ | 2,844 | ||||||
| Gross margin % | 57.3 | % | 57.2 | % | 57.5 | % | 56.0 | % | 57.0 | % | ||||||
| Research and development expenses | $ | 66 | $ | 66 | $ | 66 | $ | 68 | $ | 266 | ||||||
| Selling, general and administrative expenses | $ | 161 | $ | 157 | $ | 162 | $ | 163 | $ | 643 | ||||||
| Income from operations | $ | 157 | $ | 171 | $ | 185 | $ | 198 | $ | 711 | ||||||
| Operating margin % | 23.4 | % | 24.8 | % | 25.8 | % | 25.8 | % | 25.0 | % |
Income from operations reflect the results of our reportable segments under Agilent's management reporting system which are not necessarily in conformity with GAAP financial measures. Income from operations of our reporting segments exclude, among other things, charges related to restructuring and other related costs, asset impairments, amortization of intangibles, transformational initiatives, acquisition and integration costs, business exit and divestiture costs and change in fair value of contingent consideration.
Readers are reminded that non-GAAP numbers are merely a supplement to, and not a replacement for, GAAP financial measures. They should be read in conjunction with the GAAP financial measures. It should be noted as well that our non-GAAP information may be different from the non-GAAP information provided by other companies.
| AGILENT TECHNOLOGIES, INC. | ||||||||||||||||
| AGILENT CROSSLAB SEGMENT | ||||||||||||||||
| (Unaudited) | ||||||||||||||||
| (In millions, except margins data) | FY24 | |||||||||||||||
| Q1 | Q2 | Q3 | Q4 | Total | ||||||||||||
| Revenue | $ | 686 | $ | 664 | $ | 691 | $ | 706 | $ | 2,747 | ||||||
| Gross margin % | 56.9 | % | 56.6 | % | 57.7 | % | 56.3 | % | 56.9 | % | ||||||
| Research and development expenses | $ | 29 | $ | 26 | $ | 25 | $ | 25 | $ | 105 | ||||||
| Selling, general and administrative expenses | $ | 139 | $ | 134 | $ | 126 | $ | 133 | $ | 532 | ||||||
| Income from operations | $ | 222 | $ | 216 | $ | 248 | $ | 239 | $ | 925 | ||||||
| Operating margin % | 32.4 | % | 32.5 | % | 35.9 | % | 33.8 | % | 33.7 | % | ||||||
| FY23 | ||||||||||||||||
| Q1 | Q2 | Q3 | Q4 | Total | ||||||||||||
| Revenue | $ | 652 | $ | 660 | $ | 672 | $ | 672 | $ | 2,656 | ||||||
| Gross margin % | 55.1 | % | 53.7 | % | 56.4 | % | 55.8 | % | 55.3 | % | ||||||
| Research and development expenses | $ | 26 | $ | 27 | $ | 24 | $ | 26 | $ | 103 | ||||||
| Selling, general and administrative expenses | $ | 138 | $ | 136 | $ | 123 | $ | 129 | $ | 526 | ||||||
| Income from operations | $ | 195 | $ | 192 | $ | 232 | $ | 220 | $ | 839 | ||||||
| Operating margin % | 30.0 | % | 29.0 | % | 34.5 | % | 32.8 | % | 31.6 | % | ||||||
| FY22 | ||||||||||||||||
| Q1 | Q2 | Q3 | Q4 | Total | ||||||||||||
| Revenue | $ | 648 | $ | 613 | $ | 639 | $ | 663 | $ | 2,563 | ||||||
| Gross margin % | 55.3 | % | 54.8 | % | 55.5 | % | 56.2 | % | 55.4 | % | ||||||
| Research and development expenses | $ | 24 | $ | 23 | $ | 23 | $ | 24 | $ | 94 | ||||||
| Selling, general and administrative expenses | $ | 139 | $ | 135 | $ | 137 | $ | 137 | $ | 548 | ||||||
| Income from operations | $ | 195 | $ | 178 | $ | 194 | $ | 212 | $ | 779 | ||||||
| Operating margin % | 30.1 | % | 29.0 | % | 30.4 | % | 31.9 | % | 30.4 | % |
Income from operations reflect the results of our reportable segments under Agilent's management reporting system which are not necessarily in conformity with GAAP financial measures. Income from operations of our reporting segments exclude, among other things, charges related to restructuring and other related costs, asset impairments, amortization of intangibles, transformational initiatives, acquisition and integration costs, business exit and divestiture costs and change in fair value of contingent consideration.
Readers are reminded that non-GAAP numbers are merely a supplement to, and not a replacement for, GAAP financial measures. They should be read in conjunction with the GAAP financial measures. It should be noted as well that our non-GAAP information may be different from the non-GAAP information provided by other companies.
| AGILENT TECHNOLOGIES, INC. | ||||||||||||||||
| APPLIED MARKETS SEGMENT | ||||||||||||||||
| (Unaudited) | ||||||||||||||||
| (In millions, except margins data) | FY24 | |||||||||||||||
| Q1 | Q2 | Q3 | Q4 | Total | ||||||||||||
| Revenue | $ | 352 | $ | 305 | $ | 302 | $ | 338 | $ | 1,297 | ||||||
| Gross margin % | 56.4 | % | 54.2 | % | 55.2 | % | 55.0 | % | 55.2 | % | ||||||
| Research and development expenses | $ | 25 | $ | 23 | $ | 23 | $ | 23 | $ | 94 | ||||||
| Selling, general and administrative expenses | $ | 82 | $ | 78 | $ | 74 | $ | 77 | $ | 311 | ||||||
| Income from operations | $ | 92 | $ | 64 | $ | 70 | $ | 86 | $ | 312 | ||||||
| Operating margin % | 26.1 | % | 21.0 | % | 23.2 | % | 25.3 | % | 24.0 | % | ||||||
| FY23 | ||||||||||||||||
| Q1 | Q2 | Q3 | Q4 | Total | ||||||||||||
| Revenue | $ | 385 | $ | 331 | $ | 339 | $ | 342 | $ | 1,397 | ||||||
| Gross margin % | 57.6 | % | 54.9 | % | 55.5 | % | 55.7 | % | 56.0 | % | ||||||
| Research and development expenses | $ | 26 | $ | 26 | $ | 23 | $ | 25 | $ | 100 | ||||||
| Selling, general and administrative expenses | $ | 86 | $ | 83 | $ | 73 | $ | 77 | $ | 319 | ||||||
| Income from operations | $ | 110 | $ | 72 | $ | 92 | $ | 89 | $ | 363 | ||||||
| Operating margin % | 28.5 | % | 21.9 | % | 27.2 | % | 25.9 | % | 26.0 | % | ||||||
| FY22 | ||||||||||||||||
| Q1 | Q2 | Q3 | Q4 | Total | ||||||||||||
| Revenue | $ | 356 | $ | 304 | $ | 361 | $ | 420 | $ | 1,441 | ||||||
| Gross margin % | 55.6 | % | 54.2 | % | 55.9 | % | 56.8 | % | 55.7 | % | ||||||
| Research and development expenses | $ | 26 | $ | 25 | $ | 26 | $ | 26 | $ | 103 | ||||||
| Selling, general and administrative expenses | $ | 83 | $ | 83 | $ | 83 | $ | 84 | $ | 333 | ||||||
| Income from operations | $ | 89 | $ | 57 | $ | 93 | $ | 128 | $ | 367 | ||||||
| Operating margin % | 24.9 | % | 18.8 | % | 25.7 | % | 30.5 | % | 25.5 | % |
Income from operations reflect the results of our reportable segments under Agilent's management reporting system which are not necessarily in conformity with GAAP financial measures. Income from operations of our reporting segments exclude, among other things, charges related to restructuring and other related costs, asset impairments, amortization of intangibles, transformational initiatives, acquisition and integration costs, business exit and divestiture costs and change in fair value of contingent consideration.
Readers are reminded that non-GAAP numbers are merely a supplement to, and not a replacement for, GAAP financial measures. They should be read in conjunction with the GAAP financial measures. It should be noted as well that our non-GAAP information may be different from the non-GAAP information provided by other companies.